• Company
• Dong-A ST will exclusively supply surgical robot Versius
• by Son, Hyung-Min May 10, 2024 05:47am

• Company
• 98% relapse-free Soliris is reimbursed for NMOSD in Korea
• by Son, Hyung-Min May 10, 2024 05:47am

• Company
• Korean AI-driven drug discovery speeds up
• by Nho, Byung Chul May 10, 2024 05:46am

• Company
• 'Lixiana' dominates the DOAC market in KOR
• by Kim, Jin-Gu May 9, 2024 05:53am

• Policy
• Celltrion Pharm completes localizing 3 Edarbi products
• by Lee, Hye-Kyung May 9, 2024 05:52am

• Policy
• Name of transferred and aquired drugs can be changed in KOR
• by Lee, Hye-Kyung May 9, 2024 05:52am

• Policy
• AZ renews orphan drug Strensiq’s risk-sharing agreement
• by Lee, Tak-Sun May 9, 2024 05:52am

• Company
• Novel targeted therapy for gastric cancer 'Vyloy' may launch
• by Eo, Yun-Ho May 9, 2024 05:52am

• Company
• Novo Nordisk and Lilly post strong performance
• by Son, Hyung-Min May 8, 2024 05:48am

• Policy
• MSD’s Cancidas will retain premium pricing for up to 5 yrs
• by Lee, Tak-Sun May 8, 2024 05:48am